← FDA Drug Approvals (Drugs@FDA)

ICLUSIG

NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2012-12-14

Drug application

FDA Application #

NDA203469

Application type

New Drug Application

Brand name

ICLUSIG

Generic name

PONATINIB HYDROCHLORIDE

Active ingredients

PONATINIB HYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TAKEDA PHARMS USA

Manufacturer

Takeda Pharmaceuticals America, Inc.

First approval

2012-12-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown